The XBB variant has been driving up cases in parts of Asia,...
Category:
Health
Latest
RT-PCR test mandatory for arrivals from China, 4 other nations: Union Health Minister Mandaviya
"The RT-PCR test to be mandatory for international arrivals from...
India doesn’t need to ban int’l flights, impose lockdown right now: Experts
"Overall, there is no increase in Covid caseload and India...
Early detection of Covid cases has resulted in low fatality rate: Vardhan
India’s total coronavirus cases have increased to 8,49,553. The country now has 2,92,258 active cases out of the total that were confirmed positive. Yesterday, the tally breached the 8-lakh mark. The total number of deaths that have been reported so far has increased to 22,674. India reported 28,637 new cases in the last 24 hours.
Coronavirus bringing record $1 trillion of new global corporate debt in 2020 – report
“COVID has changed everything,” said Seth Meyer, a portfolio manager at Janus Henderson, the firm that compiled the analysis for a new corporate debt index. “Now it is about conserving capital and building a fortified balance sheet”.
Priority is close monitoring, guiding containment work in areas with high infection rate: PM Modi
According to a statement issued by the Prime minister’s Office, Modi also directed that real-time national level monitoring and guidance should be provided to all affected states and places with high test positivity rates.
India’s COVID-19 tally reaches 8.2 lakh with 27,114 new cases, death toll climbs to 22,123
While the total coronavirus caseload surged to 8,20,916 on Saturday, there were 2,83,407 active cases and 5,15,385 recoveries. The total number of confirmed cases include foreigners
“Thus, around 62.78 per cent of patients have recovered so far,” an official said
Pandemic exposes scientific rift over proving when germs are airborne
WHO still insists on more definitive proof that the novel coronavirus, which causes the respiratory disease COVID-19, can be transmitted through the air, a trait that would put it on par with measles and tuberculosis and require even more stringent measures to contain its spread.
No coronavirus patient under home isolation in Delhi has died in July: study
“During the June 24 to July 8 fortnight, a total of 691 deaths took place in Delhi, which is an average of 46 deaths per day during this period,” the government said in a statement.
According to the study, the number of daily deaths in past few days has come down. From a high of 101 daily deaths in mid-June, daily deaths have come down to around 46 deaths during the last fortnight, registering a significant improvement, it said.
Healthcare spends, making India slum-free should be govt’s priority: Experts
“To change this crisis to an opportunity, let us invest in the health sector,” SBI’s chief economist S K Ghosh said, suggesting a plan to build a 500-bed hospital in 250 districts at a cost of Rs 60,000 crore over the next two years
Covid-19 left 147 mn unemployed, global consumption loss at $3.8 trn: Study
“Our study highlights the interconnected nature of international supply chains, with observable global spillover effects across a range of industry sectors, such as manufacturing, tourism and transport,” said study researcher Arunima Malik from the University of Sydney in Australia.
Gilead analysis shows remdesivir reduced coronavirus death risk, more studies needed
Findings from the analysis showed that 74.4% of remdesivir-treated patients recovered by Day 14 versus 59.0% of patients receiving standard of care, the company said.
The mortality rate for patients treated with remdesivir in the analysis was 7.6% at Day 14, compared with 12.5% among patients not on remdesivir.
Relying on market forces for Covid-19 drugs would prolong the deadly pandemic:Bill Gates
With hundreds of vaccine projects under way and governments in Europe and the United States investing billions of dollars in research, trials and manufacturing, there is concern that richer nations could scoop up promising medicines against the new coronavirus, leaving developing countries empty-handed.
The European Commission and the World Health Organization have warned of an unhealthy competition in the scramble for a medicine seen as key to saving lives and resolving economic chaos sowed by virus, while some officials in Washington have indicated they would seek to prioritize U.S residents.